State leaders will announce the launch of a $91 million vaccine manufacturing center at Texas A&M University that will create thousands of jobs while protecting the country against future biological threats and influenza pandemics.
Gov. Rick Perry, A&M System Chancellor John Sharp and others are gathering Tuesday morning at the Capitol to discuss the collaboration involving A&M, global pharmaceutical giant GlaxoSmithKline and the federal government.
Details of the manufacturing center were first released in July but the U.S. Department of Health and Human Services recently gave federal approval to establish the center, which will be built in College Station.
State officials say the facility will anchor a larger development and manufacturing complex that's expected to generate $41 billion in expenditures in the state over the next 25 years.